Cargando…
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)
AIM: To compare the associations between concomitant liraglutide use versus no liraglutide use and the risk of major adverse cardiovascular events (MACE) and all‐cause mortality among patients receiving basal insulin (either insulin degludec [degludec] or insulin glargine 100 units/mL [glargine U100...
Autores principales: | Brown‐Frandsen, Kirstine, Emerson, Scott S., McGuire, Darren K., Pieber, Thomas R., Poulter, Neil R., Pratley, Richard E., Zinman, Bernard, Ranthe, Mattis F., Grøn, Randi, Lange, Martin, Moses, Alan C., Örsy, Petra, Buse, John B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504564/ https://www.ncbi.nlm.nih.gov/pubmed/30793465 http://dx.doi.org/10.1111/dom.13677 |
Ejemplares similares
-
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)
por: Zinman, Bernard, et al.
Publicado: (2017) -
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality
por: Pieber, Thomas R., et al.
Publicado: (2017) -
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7)
por: Pratley, Richard E., et al.
Publicado: (2019) -
Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)
por: Amod, Aslam, et al.
Publicado: (2020) -
Glomerular Filtration Rate and Associated Risks of
Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes:
Secondary Analysis (DEVOTE 11)
por: Amod, Aslam, et al.
Publicado: (2019)